Effect of Immunosuppressive Therapy on HBsAg‐Positive Chronic Active Hepatitis in Relation to Presence or Absence of HBeAg and Anti‐HBe
Evangelista Sagnelli, Felice Piccinino, Giuseppe Manzillo, Francesca M. Felaco, Pietro Filippini, Giuseppe Maio, Giuseppe Pasquale, Crescenzo M. Izzo – 1 January 1983 – Two hundred and four patients with biopsy‐proven HBsAg‐positive chronic active hepatitis were treated for at least 2 years with azathioprine, prednisolone or a combination of both, or were untreated. Prevalences of HBeAg, anti‐HBe, and anti‐HBc were 26, 58, and 100%, respectively.